A novel UCHL(3) inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair

Triple-negative breast cancer (TNBC) treatment remains a great challenge for clinical practice and novel therapeutic strategies are urgently needed. UCHL3 is a deubiquitinase that is overexpressed in TNBC and correlates with poor prognosis. UCHL3 deubiquitinates RAD51 thereby promoting the recruitme...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Death Dis
Autors principals: Song, Zhiwang, Tu, Xinyi, Zhou, Qin, Huang, Jinzhou, Chen, Yuping, Liu, Jiaqi, Lee, SeungBaek, Kim, Wootae, Nowsheen, Somaira, Luo, Kuntian, Yuan, Jian, Lou, Zhenkun
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6529448/
https://ncbi.nlm.nih.gov/pubmed/31113933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-019-1628-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars